Relation of Changes in Hepatitis B Virus Replication Markers to the Outcome of Interferon Treatment in Patients with Chronic Hepatitis
- 1 April 1992
- journal article
- clinical trial
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 4 (2) , 95-98
- https://doi.org/10.1080/1120009x.1992.11739147
Abstract
The relationship between the behavior of hepatitis B virus (HBV) replication markers and the response to treatment with recombinant alpha-2b interferon (IFN) was investigated in 11 patients with chronic hepatitis. At the end of 6 months of treatment, 4 patients showed a complete response to IFN: 2 more patients had seroconversion to HBeAb after 8 and 9 months of follow-up, respectively. The response to IFN was partial in the remaining patients. Pre-treatment levels of HBV DNA in patients showing complete response were lower than pre-treatment levels in patients with partial response: in addition, serum HBV DNA clearance during the treatment was associated with sustained remission more frequently than changes in the HBeAg/HBeAb system.Keywords
This publication has 7 references indexed in Scilit:
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis BNew England Journal of Medicine, 1990
- Histological improvement after anti-viral treatment for chronic hepatitis B virus infectionJournal of Hepatology, 1989
- Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis BGastroenterology, 1988
- Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant α-interferonHepatology, 1987
- Interferon in viral hepatitis: Role in pathogenesis and treatmentHepatology, 1986
- Detection of Hepatitis B Virus DNA Directly in Human Serum by a Simplified Molecular Hybridization Test: Comparison to HBeAg/ Anti-HBe Status in HBsAg Carriers†Hepatology, 1983
- Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine ArabinosideThe Journal of Infectious Diseases, 1981